Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick D Mitchell

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Respiratory Research|January 15, 2016
IL-25 and IL-33 induce Type 2 inflammation in basophils from subjects with allergic asthmaBrittany M Salter, John Paul Oliveria, Graeme Nusca, et al.
Clinical Pharmacology and Therapeutics|August 4, 2004
Rosuvastatin pharmacokinetics in heart transplant recipients administered an antirejection regimen including cyclosporineSteven G Simonson, Ali Raza, Paul D Martin, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 10, 2021
Clinical effects of mepolizumab in patients with severe eosinophilic asthma according to background therapy: A meta-analysisNjira Lugogo, Mark C Liu, Ian Pavord, et al.
International Archives of Allergy and Immunology|April 26, 2018
IL-33 and Its Receptor ST2 after Inhaled Allergen Challenge in Allergic AsthmaticsPatrick D Mitchell, Brittany M Salter, John Paul Oliveria, et al.
The Journal of Allergy and Clinical Immunology|January 21, 2019
Allergen challenge increases capsaicin-evoked cough responses in patients with allergic asthmaImran Satia, Richard Watson, Tara Scime, et al.
Clinical Pharmacology and Therapeutics|April 30, 2004
The effect of gemfibrozil on the pharmacokinetics of rosuvastatinDennis W Schneck, Bruce K Birmingham, Julie A Zalikowski, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 27, 2024
Phenotyping of Severe Asthma in the Era of Broad-Acting Anti-Asthma BiologicsArnaud Bourdin, Guy Brusselle, Simon Couillard, et al.
The European Respiratory Journal|July 26, 2024
Benralizumab for allergic asthma: a randomised, double-blind, placebo-controlled trialGail M Gauvreau, Roma Sehmi, J Mark FitzGerald, et al.
Tuberculosis and Respiratory Diseases|February 6, 2025
International Severe Asthma Registry (ISAR): 2017-2024 Status and Progress UpdateDésirée Larenas-Linnemann, Chin Kook Rhee, Alan Altraja, et al.
Allergy|June 26, 2024
Real-world biologics response and super-response in the International Severe Asthma Registry cohortEve Denton, Mark Hew, Matthew J Peters, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Respiratory Research|January 15, 2016
IL-25 and IL-33 induce Type 2 inflammation in basophils from subjects with allergic asthmaBrittany M Salter, John Paul Oliveria, Graeme Nusca, et al.
Clinical Pharmacology and Therapeutics|August 4, 2004
Rosuvastatin pharmacokinetics in heart transplant recipients administered an antirejection regimen including cyclosporineSteven G Simonson, Ali Raza, Paul D Martin, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 10, 2021
Clinical effects of mepolizumab in patients with severe eosinophilic asthma according to background therapy: A meta-analysisNjira Lugogo, Mark C Liu, Ian Pavord, et al.
International Archives of Allergy and Immunology|April 26, 2018
IL-33 and Its Receptor ST2 after Inhaled Allergen Challenge in Allergic AsthmaticsPatrick D Mitchell, Brittany M Salter, John Paul Oliveria, et al.
The Journal of Allergy and Clinical Immunology|January 21, 2019
Allergen challenge increases capsaicin-evoked cough responses in patients with allergic asthmaImran Satia, Richard Watson, Tara Scime, et al.
Clinical Pharmacology and Therapeutics|April 30, 2004
The effect of gemfibrozil on the pharmacokinetics of rosuvastatinDennis W Schneck, Bruce K Birmingham, Julie A Zalikowski, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 27, 2024
Phenotyping of Severe Asthma in the Era of Broad-Acting Anti-Asthma BiologicsArnaud Bourdin, Guy Brusselle, Simon Couillard, et al.
The European Respiratory Journal|July 26, 2024
Benralizumab for allergic asthma: a randomised, double-blind, placebo-controlled trialGail M Gauvreau, Roma Sehmi, J Mark FitzGerald, et al.
Tuberculosis and Respiratory Diseases|February 6, 2025
International Severe Asthma Registry (ISAR): 2017-2024 Status and Progress UpdateDésirée Larenas-Linnemann, Chin Kook Rhee, Alan Altraja, et al.
Allergy|June 26, 2024
Real-world biologics response and super-response in the International Severe Asthma Registry cohortEve Denton, Mark Hew, Matthew J Peters, et al.
Pageof 4